Podcasts about vascular

Susan Lindahl Scholarship winner Alex Toben, PA-S, speaks with Miles at the San Diego conference, where she presented her work, Vascular Evaluation in Suspected Spontaneously Reduced Tibiofemoral Dislocations: A Clinical Guide to Ankle-Brachial Index Versus Computed Tomography Angiography.

In this episode, Judy Thompson speaks to Lori Kaczmerek MSN, RN, VA-BCᵀᴹ, Petra Ostrom, BSN, RN, CIC and Tomoko Ray, MBA, RRT, CIC, VA-BCᵀᴹ. Petra and Tomoko are infection preventionists from Orlando, Florida and share a wonderful perspective related to infection prevention and vascular access. Vascular access is one of the most common interventions we perform in the hospital—but when it comes to infection prevention, are we giving every vascular access device the attention it deserves? We'll look beyond the traditional focus on central lines and explore the broader vascular access picture: peripheral IVs, arterial catheters, dressing integrity, bleeding and oozing, securement, and the everyday challenges that can create opportunities for contamination and infection. And importantly, we'll talk about hospital-onset bacteremia and what it means for infection prevention, considering the potential contribution of all vascular access devices to bloodstream infection risk.

Leg pain, swelling, numbness or cold feet can be easy to dismiss — especially when you're young and otherwise healthy. But when do those symptoms point to a circulation problem, and how early can vascular disease actually begin?In this episode, you'll learn: What vascular disease is and how it affects arteries, veins and lymphatics  Why vascular disease can develop silently for years before symptoms appear  Warning signs such as reproducible leg cramping, swelling, numbness and cold limbs  Risk factors including obesity, diabetes, high blood pressure, cholesterol, smoking and vaping  How to tell everyday leg soreness from circulation-related pain  What happens during a vascular evaluation and which tests may be used  How exercise, medications and minimally invasive treatments can help  Simple lifestyle steps that may reduce vascular risk over time Host Dr. Anthony Gonzalez talks with Dr. Young Lee, a vascular and endovascular surgeon at Baptist Health Miami Cardiac & Vascular Institute, about how to recognize vascular disease earlier and what you can do to protect your circulation for the long term.Host:Anthony Gonzalez, M.D.Chief of Surgery, Baptist Health Baptist HospitalMedical Director of Bariatric Surgery, Baptist HealthGuest:Young Christina Lee, M.D.Vascular and Endovascular Surgeon Baptist Health Miami Cardiac & Vascular InstituteIf you found this episode helpful, we also recommend the following:Heart Disease in Young Adults: Why It's Rising (And What to Watch For)Stroke Symptoms at Any Age: What You Need to KnowYoung People and Strokes: A Troubling Trend

ArticlesMedical Therapies for Vascular Anomalies: What Interventional Radiologists Need to Know (Read)Short-Term and Long-Term Changes in Renal Function Following Percutaneous Cryoablation: A Comparison of Endophytic Versus Exophytic Renal Tumors (Read)Ablative Radioembolization Dosing Thresholds for Glass Microspheres Predictive of Complete Imaging Response and Survival in Patients with Hepatocellular Carcinomas Larger than 4 cm: A Multi-institution Retrospective Analysis (Read)Safety and Impact on Sustainability of Reduced Protective Equipment inUltrasound-Guided Paracentesis: A Retrospective Cohort Study (Read)Socioeconomic Factors Impacting Survival in Patients With Hepatocellular Carcinoma Treated With Locoregional Therapies: A Single-Center Study (Read)Trends in the Concentration of Interventional Radiology Work amongRadiologists in the United States: Analysis of Medicare Claims Data, 2008–2023 (Read)HostMarie Hamel, the Warren Alpert Medical School of Brown UniversityAudio EditorAndrew Sasser, University of Miami Leonard M. Miller School of MedicineAbstract ReadersBryant Nelson, Edward Via College of Osteopathic Medicine Carolinas CampusMushira Khan, Alfaisal UniversityEmily Eng, University at Buffalo Jacobs School of MedicineClaire Kung, Albany Medical CollegeSamuel Wang, Washington University School of Medicine in St LouisDaniel Shen, Case Western Reserve University School of MedicineSupport the show

Heart & Vascular Care with Dr. Constantino Pena, Vascular and Interventional Radiologist and the System Chief of Interventional Radiology at Baptist Health Heart & Vascular CareSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of the Medical Sales Podcast, Samuel Adeyinka sits down with Pete Okonkwo, a Vascular Therapies Consultant at Boston Scientific, to give listeners an inside look at what it really takes to succeed in vascular medical device sales. Pete explains what a typical day looks like, from arriving early for procedures and managing inventory to supporting interventional radiologists, interventional cardiologists, and vascular surgeons in the cath lab and hybrid OR. He breaks down the differences between vascular therapies and his previous experience as a Surgical Account Manager, including the complexity of vascular procedures, the importance of understanding imaging and anatomy, and why reps must be able to adapt quickly as cases change. Pete also shares what it takes to manage multiple accounts, balance case coverage with business development, and build strong relationships with surgeons while maintaining emotional intelligence and situational awareness in the operating room. He discusses the importance of being a self-starter, managing your own time, staying several steps ahead during procedures, and knowing when to speak up and when to simply support the surgeon. Most importantly, Pete shares a powerful story from one of his early experiences in vascular therapies that showed him the real impact medical sales can have on patient care. Whether you're considering a career in vascular therapies, trying to understand what medical device reps actually do, or looking to become a stronger sales professional in the OR, this episode offers an honest look at the skills, mindset, and clinical knowledge required to succeed. Connect with Pete Okonkwo: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How »

Sexuality and sexual health are closely connected to your cardiovascular health, and changes in sexual function may be an important signal from your body. In this solo episode of Please Me! Podcast, Eve Hall explores the connection between blood flow, vascular health, sexual function, erectile dysfunction, vaginal dryness, sensitivity, arousal, orgasm, and sexual longevity. Healthy circulation plays an important role in genital tissue health and sexual function. Eve explains why changes in erections, vaginal sensitivity, lubrication, or arousal shouldn't automatically be dismissed as “just getting older.” She also explores lifestyle strategies and at-home tools that may help support healthy blood flow, sexual wellness, and sexual function as you age. In This Episode, You'll Learn: The connection between blood flow and sexual function Why erectile dysfunction and vaginal dryness may be connected to vascular health What nocturnal erections can tell you about circulation and sexual health The connection between sexual health and cardiovascular health The potential role of regular masturbation in sexual wellness and sexual longevity How exercise, strength training, walking, hydration, sleep, and blood pressure can affect cardiovascular and sexual health How diabetes and smoking can affect blood flow, sexual function, and sensitivity How vacuum erection devices and pumps are used in sexual health What acoustic wave therapy is and how it is being explored for erectile dysfunction and decreased vaginal sensitivity How tracking nocturnal erections and changes in sexual function may provide useful information Why sexual health and sexuality deserve a place in your overall longevity strategy How protecting cardiovascular health may also support sexual function and sexual longevity Connect with Eve: Reach out for questions, partnerships, retreats, speaking engagements, or collaborations. Boudoir posters of Eve are also available by request, with donations starting at $150. Only five signed copies of each image will be available.  Contact - Please Me!  Explore the Sexual Longevity Protocol:  https://pleaseme.online/the-sexual-longevity-protocol/ A science-based on demand 3 module course by Eve Hall, a Sexual Health Physical Therapist to help you improve sexual function, confidence, and pleasure for life. Lifetime access for just $47.  Join the Please Me Newsletter: :(1) Eve Hall | Substack   Join Eve's Eventbrite for Upcoming Webinars: Please Me! Media  Affiliate Deals & Partners: • Become a Patreon of Please Me! Media: https://www.patreon.com/PleaseMePodcast • Parlor Games Bioidentical Hormones: Parlor Games | Shop  • Shameless Care: Sex Positive Healthcare: (Code: PLEASEME): STD Testing, STD Prevention, and ED Meds - Shameless Care  • Become a member for free monthly webinars (Code: PLEASEME): SDC Swingers Lifestyle: Seek, Discover, Connect | SDC.com  • Lady Pump: Lady Pump – TheLadyPump  • Penis Pump: Auto GRO Pump - Dr. Joel Kaplan  • Cakes Nipple Covers: (Code: CAKES-PLEASEME 10% off) Sticky Starter Pack | Our Best Sticky Offer, $33 Savings – CAKES body  Thank you for supporting my affiliate partners. Every purchase helps support Please Me! Media's mission. The Mom Economy Anthology Book is A USA Bestseller! Now available in Hard Cover or Paperback.  I'm proud to be part of this collaboration. My chapter is deeply personal and shares what I most want my daughters—and the next generation of women—to know.  Purchase ALL version here:  https://a.co/d/01HpPGN2  The Mom Economy Magazine:  Check out my featured article of this magazine for only $2.99 here:  The Mom Economy Magazine | July 2026 Edition | She Rises Studios  Be a Guest On Please Me! A Sexuality Podcast: :Be a Guest on Please  Me! PodcastShare your story or expertise on relationships, sexual health, and personal growth

9/1/2026 | Vascular

Gross contamination of vascular access devices can occur when catheter connections, hubs, tubing, or primary dressings are exposed to bodily fluids, moisture, environmental debris, or other contaminants. These events may be especially visible in pediatric care, but the underlying risks are relevant across settings, including adult critical care, oncology, home infusion, and long-term vascular access.In this episode, a Pediatric Clinical Nurse Specialist from Seattle Children's Hospital will draw on real-world clinical experience to discuss everyday contamination risks, why they matter, and how clinicians can better prevent, recognize, and respond to them.AVA would like to thank Covalon for supporting this episode.Watch the podcast on YouTube

New minimally invasive treatments for arthritis and chronic joint pain are giving some patients options beyond medications, injections and more invasive surgery. Vascular surgeon Dr. Daniel Nathanson explains Genicular Artery Embolization (GAE), MSK embolization and how image-guided vascular techniques are being used to target inflammation and pain. Dr. John Phillips and I welcome Dr. Daniel Nathanson of the San Francisco Vein & Vascular Institute in San Francisco, California, for a fascinating look at how tools traditionally associated with vascular intervention are expanding into the treatment of musculoskeletal pain. Dr. Nathanson is a board-certified vascular and endovascular surgeon who specializes in minimally invasive, image-guided treatments. His work includes Genicular Artery Embolization (GAE) for knee osteoarthritis as well as musculoskeletal or MSK embolization for chronic pain involving areas such as the shoulder, hip and other joints. So how does embolization help arthritis pain? Rather than replacing a joint, these procedures use a tiny catheter to reach abnormal blood vessels associated with inflammation. The goal is to reduce that inflammatory blood flow and, in appropriately selected patients, reduce pain and improve function. For knee osteoarthritis, GAE is being explored as a minimally invasive option for patients who continue to have pain despite conservative treatment and are looking for alternatives to knee replacement. We also explore how this concept is moving beyond the knee. Dr. Nathanson discusses emerging applications of MSK embolization for chronic joint and tendon pain involving the shoulder, hand and wrist, hip, knee, Achilles tendon, plantar fascia and more. If you are dealing with osteoarthritis, chronic knee pain or persistent joint pain, this conversation will help you understand where these newer minimally invasive treatments may fit, who may be a candidate, and why vascular specialists are becoming part of a rapidly evolving area of arthritis care. Learn more about Dr. Daniel Nathanson and San Francisco Vein & Vascular Institute: San Francisco, California Search: San Francisco Vein & Vascular Institute / Dr. Daniel Nathanson Need help with Peripheral Artery Disease or another opinion before an amputation? Call the Global PAD Association Leg Saver Hotline: 1-833-PAD-LEGS Find PAD clinical trials and research opportunities: PADTrials.org Join The Great Circulation Challenge Help us walk the 60,000 miles of the human circulatory system together. SIGN UP: www.TheGreatCirculationChallenge.org Subscribe to @TheWayToMyHeart for more conversations on new treatments, vascular disease, circulation, PAD, limb salvage and medical innovation. Please LIKE, COMMENT, SUBSCRIBE & SHARE. If you know someone living with arthritis or chronic joint pain who is looking for treatment options, send them this conversation. #Arthritis #Osteoarthritis #KneePain #GenicularArteryEmbolization #GAE #MSKEmbolization #ArthritisTreatment #JointPain #MinimallyInvasive #KneeArthritis #ChronicPain #VascularSurgery #DrDanielNathanson #MedicalInnovation

This week we review the use of right axillary artery access for aortic valvuloplasty in infants. Why would this approach potentially offer advantages versus the more traditional femoral or even carotid approach? What are the particular dangers of this approach? How should the interventionist pick the approach when planning an aortic valvuloplasty in an infant with valvar aortic stenosis? We speak with Dr. Jameel Al-Ata of King Faisal Specialist Hospital in Jeddah, Saudi Arabia this week. DOI: 10.1007/s00246-025-03991-6

Dr. Edson Lucas Colomé, Cirurgião Vascular e Dr. Murilo Moraes, Especialista em Diagnóstico Vascular, participaram do programa Arauto Saúde para falar sobre cirurgias vasculares, lipedema e diagnósticos.

Dr. Edson Lucas Colomé, Cirurgião Vascular e Dr. Murilo Moraes, Especialista em Diagnóstico Vascular, participaram do programa Arauto Saúde para falar sobre cirurgias vasculares, lipedema e diagnósticos.

NADA PERSONAL con Anabella Messina 22-08-2026 Entrevistas a: Dra. Virginia Pujol Lereis @VirgiPL (MN n° 119.987, Médica Neuróloga, Actual Jefa del Servicio de Neurología Vascular en Fleni) Julia y Nicolás (Alumnos de UTN , Equipo de Fórmula) Marina Bertone @marina_bertone (Integrante de la ONG Argentinos por la educación) Pablo Montllau (Productor, Director de Cine Documental. La Imagen Real y La Imagen Santa) Nataniel Uner (Dígale Sí a la Bici)

Dra. Virginia Pujol Lereis @VirgiPL (MN n° 119.987, Médica Neuróloga, Actual Jefa del Servicio de Neurología Vascular en Fleni) Nada Personal @animessina

Vascular occlusion is one of the most serious — and most misunderstood — complications in filler injections. In this episode, Dr. Judith Borger breaks down exactly what vascular occlusion is, why it happens, the anatomical danger zones every injector should know cold, and the warning signs every patient should be able to recognize. This isn't a scare-tactic episode — it's an honest, clinical walkthrough from a board-certified physician, designed to help you ask better questions and feel more confident in the chair. In this episode: What vascular occlusion actually is (and how it differs from normal bruising or swelling) The two mechanisms: direct intravascular injection vs. extravascular compression High-risk anatomical zones: glabella, nose, tear trough, temple Warning signs to watch for: disproportionate pain, blanching, dusky/mottled skin What to do immediately if you notice these signs A brief overview of how it's managed and why HA filler's reversibility matters Questions to ask your injector before treatment Dr. Judith Borger Links: www.theaestheticdoctor.com www.instagram.com/doctorborger

Commentary by Dr. Alena Shantsila.

Dr. Maya Patel and Dr. Tetyana Gorbachova explore key vascular variants of the upper and lower extremities that radiologists may encounter on routine musculoskeletal imaging, highlighting how to recognize them and understand their clinical significance. They discuss the surgical implications of variants such as the persistent median artery, corona mortis, persistent sciatic artery, and aberrant anterior tibial artery, emphasizing how accurate identification can help prevent serious complications including neuropathy, hemorrhage, limb ischemia, and amputation. Charting Variant Vascular Pathways in Musculoskeletal Imaging: Clinical and Surgical Implications. Patel et al. RadioGraphics 2026; 46(3):e250073. 

Comparing Marfan Syndrome, Loeys-Dietz Syndrome, and Vascular EDS   Guest: Juan Bowen, M.D. Host: Paul Friedman, M.D.   Marfan syndrome, Loeys-Dietz syndrome, and vascular Ehlers-Danlos syndrome are clinical problems seen in an aortic clinic. Thoracic aortic aneurysm is a common feature, but the three conditions differ in the severity of aortic and arterial disease and in the types of extracardiac problems that require management. Making an accurate diagnosis is an essential first step in their successful management.   Topics Discussed: What mutations cause Marfan syndrome, Loeys-Dietz syndrome, and the vascular Ehlers-Danlos syndrome? What is the natural history of these three conditions? How is aortic and vascular disease managed in these three conditions? What are the non-cardiac problems most often encountered in these three conditions?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded on: 17-February-2026

How is AI reshaping the way radiology residents study, dictate reports, and summarize clinical courses? BackTable co-founder Anish Parikh catches up with Dr. Sunny Murthy, a PGY-2/R1 integrated interventional radiology (IR) resident at the University of Virginia (UVA). --- Get the BackTable apphttps://www.backtable.com/app --- More about this episode Dr. Murthy outlines the lecture structure (morning didactics, noon case-based sessions) and a curriculum shift toward on-demand video learning via Modality, alongside books, Radiopaedia, and targeted journal use. They discuss conference learning at SIR, the role of podcasts like BackTable, and balancing information overload. AI comes up in both clinical workflows (Epic-generated hospital-course summaries that can be wrong) and education (Claude/Notion for organizing study), with debate about limiting AI for trainees versus preparing for future practice. The resident explains learning procedures across multiple devices, relying on techs, industry training and exhibit halls, and notes receiving a resident teaching award while emphasizing the need for better IR exposure and simulation-based training content. --- Resources Fundamentals of Body CThttps://www.us.elsevierhealth.com/fundamentals-of-body-ct-9780323608329.html Journal of Vascular and Interventional Radiologyhttps://www.jvir.org/ CardioVascular and Interventional Radiologyhttps://www.cvironline.org/ --- Backtable Industry is the go-to podcast for healthcare leaders, business-minded providers, and innovators that are shaping the future of healthcare. Download the free BackTable app to get early access to new episodes.► https://www.backtable.com/app

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Gayatri Devi is a nationally recognized neurologist specializing in memory disorders, including Alzheimer's disease and related dementias. In this episode, Gayatri explains how to think about dementia as a spectrum—including Alzheimer's disease, vascular dementia, Lewy body dementia, and mixed presentations—while exploring the evolving biology of amyloid, tau, and neuroinflammation and why brain pathology does not always correlate with symptoms. She discusses her approach to detecting subtle cognitive decline in high-functioning individuals, the role of biomarkers and APOE4 testing in asymptomatic patients, the benefits and risks of anti-amyloid therapies such as lecanemab and donanemab, and strategies for minimizing treatment-related complications. Gayatri also examines why some patients may stabilize or even improve with individualized care, the overlap among different dementia syndromes, and the relationship between menopause, estrogen, and cognition—including her concept of menopause-related cognitive impairment. Finally, she discusses how advances in early detection, AI-assisted monitoring, targeted therapies, and precision medicine are reshaping the future of dementia care. We discuss: Gayatri's training and clinical focus, why dementia is a spectrum disease, and how personalized treatment is changing Alzheimer's care [3:45]; How Alzheimer's disease fits within the broader spectrum of dementia: diagnosis, biomarkers, and early pathophysiology [7:15]; The emerging role of neuroinflammation and viral infections in Alzheimer's disease [13:30]; Gayatri's comprehensive approach to evaluating cognitive decline in high-functioning patients [17:45]; Why forgetting names is usually normal and when word-finding problems become concerning [29:00]; Why women are at higher risk for Alzheimer's disease and how menopause influences cognition [33:45]; The promise and limitations of blood-based biomarkers for diagnosing Alzheimer's disease [40:15]; When preclinical Alzheimer's screening is appropriate and how to interpret positive biomarker results [45:00]; Case study: early Alzheimer's prevention in a highly-functional woman in her 50s with two copies of APOE4 [47:15]; Anti-amyloid therapies: balancing clinical benefit with ARIA risk using slow titration [51:45]; The aducanumab controversy, why it was discontinued, and why Gayatri would still choose it [1:00:00]; How anti-amyloid therapies cause ARIA, strategies for detecting and managing these complications, and how future therapies may improve safety and accessibility [1:03:30]; Two patient examples of exceptional responses to anti-amyloid therapy [1:12:30]; A multimodal approach to Alzheimer's treatment: combination therapy, MRI-guided TMS, GLP-1 receptor agonists, and more [1:15:00]; Vascular dementia, Lewy body dementia, and the overlap with Alzheimer's disease [1:21:00]; Lewy body dementia and Parkinson's disease: distinguishing two alpha-synuclein disorders [1:26:45]; Risk factors for Lewy body dementia and what remains unknown [1:36:15]; Treating menopause-related cognitive impairment: hormone therapy, brain rehabilitation, and balancing breast cancer risk [1:38:45]; How biomarkers changed Gayatri's perspective on the potential for Alzheimer's patients to improve [1:47:15]; The future of Alzheimer's care: AI, precision medicine, and personalized treatment [1:49:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

If you love facilitating workshops and trainings, but you know there's something more you want to say, this episode is for you.My guest is Corrin McCloskey, a healthcare executive, speaker, writer, and facilitator who has made the leap from being a fabulous facilitator into a true thought leader. Corrin joined us in Thought Leader Academy in January 2025, and in the year and a half since then, she has spoken at multiple national conferences, published writing in her field, and continued building momentum around her message: healthcare needs more human-centered, connected, and courageous leadership.This conversation is part of our Expert Trap series because Corrin's story is such a powerful example of what happens when you move beyond simply teaching helpful content and start naming what's missing in the conversation.We talk about:How Corrin shifted from facilitating strategic planning and leadership workshops to speaking on bigger stagesWhy thought leadership is less about having all the answers and more about sharing a clear perspectiveThe role of writing in expanding your ideas beyond a single talkHow to keep putting your work out there, even when it doesn't feel perfectWhat Corrin learned from both deeply affirming audience feedback and a painful experience of harassment after a speaking engagementWhy having a support system matters when you're using your voice more publiclyWhat I love about Corrin's journey is that she didn't abandon facilitation. She built on it. She took the skills she already had, added her lived experience and perspective, and stepped into a bigger conversation.That's the real invitation of thought leadership: to stop hiding behind expertise alone and start using your voice for the change you want to see.About Our Guest: Corrin McCloskey is a healthcare executive, executive coach, and national speaker focused on leadership, culture, and change management in healthcare. She serves as Vice President of Heart & Vascular and Oncology Services at Tanner Health, where she leads strategy, growth, and service line development. Passionate about helping leaders build trust and navigate complexity, Corrin frequently speaks on physician leadership, organizational culture, and leading change in healthcare. Over the past year, she has expanded her national speaking presence and contributed thought leadership focused on creating healthier, more sustainable healthcare systems.About Us: The Speaking Your Brand podcast is hosted by Carol Cox. At Speaking Your Brand, we help women entrepreneurs and professionals clarify their brand message and story, create their signature talks, and develop their thought leadership platforms. Our mission is to get more women in positions of influence and power because it's through women's stories, voices, and visibility that we challenge the status quo and change existing systems. Check out our coaching programs at https://www.speakingyourbrand.com. Links:Show notes at https://www.speakingyourbrand.com/480/ Corrin's website: https://corrinmccloskey.com/ Watch Corrin deliver her signature talk on our live show: https://www.youtube.com/live/rhDAdGR44-g?si=MulG_sPQ0-MmpLK4 Discover your Speaker Archetype by taking our free quiz at https://www.speakingyourbrand.com/quiz/Enroll in our Thought Leader Academy: https://www.speakingyourbrand.com/academy/ Connect on LinkedIn:Carol Cox = https://www.linkedin.com/in/carolcoxCorrin McCloskey (guest) = https://www.linkedin.com/in/corrinmccloskey/ Related Podcast Episodes:Episode 478: The Expert Trap: Why Great Speakers Don't Become Thought LeadersEpisode 391: Claiming Your Identity as a Speaker and Thought Leader

Join us for happy hour! In our new episode of The AJP-Heart and Circ Podcast, Associate Editor Dr. Amanda LeBlanc (University of Louisville) hosts a casual, witty, and engaging conversation with co-authors Dr. Camilla Wenceslau (University of South Carolina), Dr. Pooneh Bagher (University of Nebraska Medical Center), Dr. Brant Isakson (University of Virginia), Dr. Thomas Jepps (University of Copenhagen), and Dr. Aaron Trask (Nationwide Children's Hospital). The topic at hand for this lively group? The latest must-read Guidelines in Cardiovascular Research article by McCarthy et al. on evaluating endothelial function in vascular tissue. Listen now…you'll laugh a little and learn a lot.   Cameron G. McCarthy, Christian Aalkjær, Pooneh Bagher, Andreas M. Beyer, Ebbe Boedtkjer, Gisele F. Bomfim, Jerome W. Breslin, Ana M. Briones, Jorge A. Castorena-Gonzalez, Tiago J. Costa, Zhiyu Dai, Ana P. Davel, Scott Earley, Julie K. Freed, Christopher Garland, Brant E. Isakson, Thomas A. Jepps, Joanna Kalucka, Boris Lavanderos, Ayako Makino, Charles E. Norton, Steven S. Segal, Wenbin Tan, Aaron J. Trask, Calum Wilson, Scott D. Zawieja, and Camilla F. Wenceslau Guidelines for evaluating endothelial function in vascular tissue Am J Physiol Heart Circ Physiol, published May 1, 2026. DOI: 10.1152/ajpheart.00656.2025

A patient with a dying leg won't drive 20 miles for care. In Devin Zarkowsky's town, that's not a hypothetical. Vascular surgeon Devin Zarkowsky runs a solo office-based practice in a San Diego County town where peripheral arterial disease patients had nowhere local to go, and Jason McKittrick is the executive director of the Office-Based Facility Association. They discuss the KevinMD article "Why local care matters for peripheral arterial disease." You will hear how the Medicare physician fee schedule pays hospitals for big-ticket equipment but pays solo doctors out of the same bundled rate they use to cover staff and wire and drapes, why a four-figure atherectomy or Shockwave catheter swallows a week of revenue when there is no separate reimbursement, and why Congress is finally looking at fixing it after years of small fixes that did not close the gap. You will hear what local care actually means when a patient cannot drive and the limb cannot wait. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

A conversation with Dr. John Wong Find the video of this conversation at https://youtu.be/52HSuhvggRA

7/1/2026 | Vascular

7/1/2026 | Vascular

With Tom De Potter, Cardiovascular Research Center Aalst, Aalst - Belgium, Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia and Micaela Ebert, Heart Center - University Hospital Dresden, Dresden - Germany. In this podcast, we explore the latest clinical consensus statement on vascular access and closure management for electrophysiological interventions, highlighting best practices to improve procedural safety and patient outcomes in 2025.

This episode features Dr Lois Rajcan, an Infusion Therapy and Vascular Access Standards of Practice 10th edition committee member, discussing best practices, standards, and organizational strategies for safe port access. Learn about the importance of competency, evidence-based practices, and patient-centered care in vascular access management.

¡Bienvenidos y bienvenidas a SINNNapsis!En este capítulo conversaremos con el Dr. Edgar Nathal Vera, neurocirujano vascular, adscrito al Servicio de Neurocirugía del Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez" (INNN), Director Médico del Instituto y profesor titular del Programa de Alta Especialidad en Neurocirugía Vascular, sobre las malformaciones arteriovenosas cerebrales (MAV). Estas credenciales coinciden con su trayectoria académica y asistencial pública.Las malformaciones arteriovenosas cerebrales son conexiones anormales entre arterias y venas que alteran el flujo sanguíneo normal del cerebro. Aunque pueden permanecer asintomáticas, representan una de las principales causas de hemorragia cerebral en pacientes jóvenes. En este episodio exploraremos su historia natural, los factores que aumentan el riesgo de ruptura, la controversia en torno al estudio ARUBA y cómo actualmente se individualiza la decisión entre observar o tratar una MAV mediante microcirugía, embolización, radiocirugía o estrategias multimodales.Visítanos en todas nuestras redes sociales.Aclaración: El contenido de este podcast tiene la finalidad de brindar información científica dirigida a un público con formación profesional en áreas de la salud. Los temas aquí presentados no pueden (ni pretenden) reemplazar la relación que usted tenga con su profesional sanitario; no se deberán considerar como un consejo médico, ni tienen tal finalidad. Los casos clínicos discutidos no corresponden a ningún paciente real que haya sido atendido por los conductores o el INNN; han sido elaborados exclusivamente con fines didácticos y de divulgación de la ciencia.

CORE RESOURCES: Rutherford's Vascular and Endovascular Therapy 10th Edition, Chapters 88, 89, 91, and 94 Atlas of Vascular Surgery and Endovascular Therapy 2nd Edition, Chapter 9 ADDITIONAL RESOURCES: Audible Bleeding Episodes Holding Pressure - Carotid Endarterectomy: https://www.audiblebleeding.com/2024/02/27/holding-pressure-carotid-endarterectomy/ Holding Pressure Case Prep - Endovascular Basics: https://www.audiblebleeding.com/2023/04/23/holding-pressure-case-prep-endovascular-basics/ Videos TCAR Technical Video: https://jnis.bmj.com/content/14/8/842 Articles Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease:  https://www.jvascsurg.org/article/S0741-5214%2821%2900893-4/fulltext Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system: https://www.jvascsurg.org/action/showPdf?pii=S0741-5214%2816%2931862-6 Referenced Studies ROADSTER-1 https://pubmed.ncbi.nlm.nih.gov/30611582/ ROADSTER-2 https://pubmed.ncbi.nlm.nih.gov/32811386/ https://pubmed.ncbi.nlm.nih.gov/35381327/ TCAR Surveillance Project https://jamanetwork.com/journals/jama/fullarticle/2757579?utm_source=openevidence&utm_medium=referral https://pubmed.ncbi.nlm.nih.gov/36172943/   OUTLINE:   CAROTID ARTERY DISEASE 1. Pathophysiology/etiology Carotid artery disease is primarily driven by atherosclerotic plaque deposition.  Risk factors: hypertension, hyperlipidemia, diabetes, smoking, and advanced age. Nonatherosclerotic etiologies: fibromuscular dysplasia, carotid dissection, vasculitic disease, carotid webs, and trauma. When the endothelium is damaged, monocytes migrate to the site and differentiate into macrophages that take up oxidized LDL particles to become foam cells. Meanwhile, an inflammatory response occurs where activated platelets release thromboxane A2, platelet derived growth factor, and inflammatory cytokines that promote further platelet aggregation and vascular inflammation. Smooth muscle cells migrate and proliferate, forming the structural framework of the atheroma.  Within the lesion, necrotic debris and lipid accumulate, creating a vulnerable plaque. Plaque rupture exposes this material to the bloodstream, serving as a nidus for thrombus formation which can lead to ischemic events. Carotid bifurcation is particularly prone to plaque formation due to turbulent blood flow. Embolization of plaque from this area can result in TIA or ischemic stroke.  2. Presentation Patients are often asymptomatic and stenosis is incidentally found on imaging.  Symptomatic patients present with neurologic symptoms including unilateral motor and sensory loss, aphasia (difficulty finding words), dysarthria (difficulty speaking), amaurosis fugax (temporary monocular vision loss due to embolus to the ophthalmic artery), transient ischemic attacks Physical exam findings may be notable for auscultation of a carotid bruit. Patients may also have evidence of retinal artery embolization on fundoscopic examination (Hollenhorst plaque) or asymptomatic cerebral infarction.  3. Diagnosis USPTF recommends against screening for asymptomatic carotid artery stenosis.  In patients with no risk factors, SVS recommends against screening for asymptomatic carotid artery stenosis. However, they do recommend screening for asymptomatic clinically significant carotid bifurcation in certain groups of patients with multiple risk factors.  These risk factors include patients with clinically significant peripheral vascular disease, patients 65 and older with history of CAD, smoking, hypercholesterolemia, and patients prior to coronary artery bypass.  Relevant findings on physical exam or imaging findings may warrant screening, but screening is not recommended for the presence of neck bruit alone without other risk factors, as this finding has a low sensitivity and specificity for detecting clinically significant carotid artery stenosis.  Carotid duplex ultrasound: first-line imaging modality for both screening and initial evaluation of stenosis, noninvasive, low-cost CTA: rapid, high-resolution, three-dimensional imaging of vascular anatomy, risk of contrast and radiation exposure MRA: high-quality, three-dimensional imaging without radiation or contrast, expensive with longer acquisition time, can overestimate stenosis in severe disease DSA/angiography: gold standard, expensive, invasive, not generally recommended for routine diagnostic evaluation or screening 4. Classification Carotid artery stenosis is classified by degree of luminal narrowing. NASCET method: standard in current practice. Compares the minimal residual lumen at the point of greatest stenosis to the diameter of the normal distal internal carotid artery.  Classification of stenosis: Mild: 70 bpm, and ACT >250 seconds to optimize cerebral perfusion and minimize thrombotic risk. Clamp the carotid artery just proximal to the arterial sheath to establish active flow reversal.  Flow controller settings: Low setting High setting Flow-stop button: allows for temporary cessation of flow (used when we inject contrast).  Confirm flow reversal via two different ways:  The first way is to stop flow to the venous return sheath with the stopcock, clearing the line with hep saline injection, and then opening the stopcock and seeing the blood returning to the controller in a reverse fashion. The second way is to perform an angiogram with a small amount of contrast injection while holding the flow-stop button. Using the angio we want to make sure that contrast is flowing retrograde in the cervical ICA thereby confirming flow reversal.    Carotid artery stenting, balloon angioplasty, and completion angiogram At this point, a standard carotid angioplasty and stenting procedure is performed. ENROUTE transcarotid Neuroprotection System device:  inner diameter of 8F and an outer diameter of 10F Has its own carotid artery stent system but is also compatible with all FDA-approved carotid stents.  Final angiogram is performed to confirm stent position, vessel patency, and absence of complications including vasospasm at the distal end of the stent and filling defects from protrusion of atheromatous material through the stent    Cessation of flow reversal and sheath removal Allow the flow reversal to run for a few minutes after the final balloon angioplasty to clear any debris.  Antegrade flow is restored by releasing the carotid clamp and closing the stopcocks on the neuroprotection system.  The patient is auto-transfused the blood from the flow line back to the venous system.  As the arterial access system is removed and the puncture site is closed with the U-stitch.  IV protamine is administered to reverse the heparin. Standard closure is performed at the incision site. Meanwhile, hemostasis is achieved after removal of the femoral vein sheath with brief manual compression.  Postop care/complications Postop care All patients after a TCAR should be monitored in the ICU setting for 24 hours, as an embolic stroke, hypotension with or without bradycardia, or hypertension can occur.  Should a TIA or stroke be observed, a carotid duplex scan and CT angiogram should be immediately obtained to assess the stent site and the presence of an embolic or thrombotic filling defect, dissection, or occlusion.  Dual antiplatelet therapy: continue for 45 days to 12 months Aspirin and statin therapy: continued indefinitely Surveillance duplex imaging: 4 weeks, 6 months, and 12 months, and annually thereafter. Postop complications Hematoma Stroke Myocardial infarction Cerebral hyperperfusion syndrome Sudden and excessive increase in cerebral blood flow to previously hypoperfused brain tissue is met with vasculature that cannot constrict appropriately from chronic vasodilation Leads to breakthrough hyperperfusion. This results in cerebral edema, intracerebral hemorrhage, and neurological symptoms.  Cranial nerve injury Hypoglossal nerve (CN XII) injury: ipsilateral tongue deviation. It is the most commonly injured cranial nerve.  Vagus nerve (CN X) injury: hoarseness and possible vocal cord paralysis.  Glossopharyngeal nerve (CN IX) injury: soft palate dysfunction.  Recurrent laryngeal nerve injury: voice hoarseness and inability to cough as it innervates all of the voice box muscles except for the cricothyroid muscle Marginal mandibular nerve injury: ipsilateral lip droop, injury is rare in TCAR.  Stent restenosis Pseudoaneurysm Access site infection

Welcome to the Paint The Medical Picture Podcast, created and hosted by Sonal Patel, BA, CPMA, CPC, CMC, ICD-10-CM.Thanks to all of you for making this a Top 15 Medical Billing & Coding Podcast for 5 years on Feedspot.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sonal's 18th Season starts up and Episode 4 features Newsworthy updates on the month's fraud, waste, and abuse cases. Sonal's Trusty Tip and compliance recommendations focus on documentation requirements for noninvasive vascular studies.Spark inspires us all to reflect on all things fear based on the inspirational words of Jack Canfield.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Paint The Medical Picture Podcast now on:Spotify:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://open.spotify.com/show/6hcJAHHrqNLo9UmKtqRP3X⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://podcasts.apple.com/us/podcast/paint-the-medical-picture-podcast/id153044217⁠7⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Amazon Music: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://music.amazon.com/podcasts/bc6146d7-3d30-4b73-ae7f-d77d6046fe6a/paint-the-medical-picture-podcas⁠t⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Find Paint The Medical Picture Podcast on YouTube:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCzNUxmYdIU_U8I5hP91Kk7A⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Find Sonal on LinkedIn:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/sonapate/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠And checkout the website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://paintthemedicalpicturepodcast.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠If you'd like to be a sponsor of the Paint The Medical Picture Podcast series, please contact Sonal directly for pricing: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠PaintTheMedicalPicturePodcast@gmail.com

Vascular access is the lifeline for people on dialysis. Today we'll cover the different types, how doctors determine the best option, what the surgery and recovery involve, and more! Today we're joined by Dr. Vandana Dua Niyyar, and kidney warrior Brittany Dickerson to discuss vascular access–an important topic that will hopefully help you all listening feel more informed and confident in your care.  In today's episode we heard from:  Vandana Dua Niyyar is Professor of Medicine in the Division of Nephrology and has received the Clinical Distinction of Master Physician at Emory University. Dr. Niyyar is passionate about promoting multidisciplinary collaboration in research and education in the field of vascular access; with the ultimate goal of optimizing access care and processes for dialysis patients. She currently serves as Immediate Past President of the American Society of Diagnostic and Interventional Nephrology (ASDIN). Dr. Niyyar has been recognized for her exemplary clinical and service achievements through various awards including ASDIN Distinguished Service Award in 2019, Emory Nanette Wenger Service Award in 2019, ASN Mid-Career Distinguished Clinical Service Award in 2020, ANIO Clinical Excellence Award in 2021, Emory DOM Outstanding Quality Achievement Award in 2022 and and ASDIN Gerald Beathard Award in recognition of her teaching excellence, scholarly activity, and clinical excellence in 2024. Brittany Dickerson- I am a dedicated mother, motivational speaker, and compassionate life coach living with Polycystic Kidney Disease (PKD). I use my kidney failure battle to educate and help others regarding kidney disease and transplantation. My personal journey has fueled my passion for helping others navigate life's challenges with courage and grace. Through partnership with the National Kidney Foundation, I have had the opportunity to mentor others and to be a guest for the National Kidney Foundation Podcast channel. My dedication to kidney awareness has led me to pursue becoming a National Kidney Foundation Advocate. I use my voice to spread my powerful message of perseverance and hope. My goal is to continue making an impact on individuals facing adversity, offering guidance, support, and being a shining example of strength in the face of hardship.   Additional Resources Vascular Access Guidelines   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.  

Rachel Ludwig, Partner, DLA Piper, speaks with John Saran, Partner, Holland & Knight, Regan Parker, CEO, Association for Responsible Healthcare Investment, and Robbie Allen, CEO, U.S. Heart & Vascular, about the latest legal and regulatory developments related to corporate ownership of health care providers. They discuss the recent evolution of these laws and regulations at the state level, recurring trends, unintended consequences, and what the industry is doing to build trust and help shape the legal and regulatory landscape. From AHLA's Business Law and Governance Practice Group.Watch this episode: https://www.youtube.com/watch?v=Z9LWJzUczjkLearn more about AHLA's Business Law and Governance Practice Group: https://www.americanhealthlaw.org/practice-groups/practice-groups/business-law-and-governance Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/. 

This episode is brought to you by The Primal Skincare. Vascular surgeon Dr. Lily Johnston breaks down the definitive science of heart attack prevention and evaluates how modern diet and lifestyle choices directly accelerate or mitigate your cardiovascular risk. We explore the complex biological mechanisms underlying plaque formation and arterial rupture, moving beyond outdated dogmas to examine the real drivers of vascular disease: chronic inflammation, metabolic dysfunction, and the direct effects of insulin and glucose on your endothelial lining. Whether you are navigating the nuances of cholesterol management or looking for the most accurate diagnostic testing, this episode provides an authoritative, evidence-based roadmap to optimize your heart health and protect your arteries.In This Episode, We Reveal:The Pathophysiology of Plaque: How arterial plaque forms, why it ruptures, and the crucial clinical distinction between volatile soft plaque and stable calcified plaque.The Metabolic Drivers: The profound impact of chronic glucose and insulin elevation on arterial degradation.Advanced Diagnostics: Why standard lipid panels fail to show the whole picture, and how advanced imaging tools can detect early-stage disease.The Cholesterol Matrix: A scientific contextualization of LDL, the complexities of HDL, and whether elevated markers are a true risk factor on low-carbohydrate diets.Dietary Realities: A medical critique of common foods, the cardiovascular impact of processed ingredients, and the evidence supporting the Mediterranean diet.Scientific Resources & Dr. Johnston's Work:Dr. Lily Johnston (YouTube): https://www.youtube.com/@lilyjohnstonmdCleerly Health: https://cleerlyhealth.com/CardioRisk Ultrasound Testing: https://cardiorisk.com/HeartFlow CT Analysis: https://www.heartflow.com/

What if one of the most popular non-surgical procedures in aesthetic medicine is also one of the most misunderstood?In this episode of Plastic Surgery Uncensored, Dr. Rady Rahban takes an in-depth look at liquid rhinoplasty—a procedure that has surged in popularity thanks to its promise of immediate results, minimal downtime, and the ability to alter the appearance of the nose without surgery.But beneath the appeal lies a far more complex reality.Dr. Rahban breaks down what liquid rhinoplasty actually is, the anatomical principles that make it effective in certain situations, and why it is often being used to address concerns it was never designed to correct. He explains which patients may benefit from strategically placed filler, why others are poor candidates, and how an incomplete understanding of nasal anatomy can lead to devastating consequences.This conversation goes far beyond social media transformations and before-and-after photos. It explores the limitations of filler, the importance of proper patient selection, and the potentially catastrophic complications that can occur when injections are performed in one of the most anatomically complex regions of the face—including vascular occlusion, tissue necrosis, and even blindness.If you've ever considered a liquid rhinoplasty, been told filler can "fix" your nose, or want to understand the difference between temporary camouflage and true structural correction, this episode is essential listening.Topics covered include:• What liquid rhinoplasty actually is• How filler can improve select nasal contour irregularities• Who may be an appropriate candidate• Why some noses should never be treated with filler• The limitations of non-surgical nose reshaping• Vascular occlusion and tissue necrosis explained• The rare but devastating risk of blindness• Why nasal anatomy matters• Liquid rhinoplasty vs. surgical rhinoplasty• When surgery is the more appropriate solutionThis is a thoughtful, evidence-based discussion about one of aesthetic medicine's most controversial procedures—and the information every patient should understand before allowing anyone to inject their nose.✨ If you enjoyed this episode of Plastic Surgery Uncensored:✔️ Subscribe on Apple Podcasts, Spotify, or wherever you listen.✔️ Rate & Review—your feedback helps more people find us.✔️ Follow Dr. Rady Rahban across all platforms for daily insights, behind-the-scenes, and patient education:Instagram: @drradyrahbanTikTok: @radyrahbanMDYouTube: @Rady RahbanFacebook: @Rady Rahban✔️ Share this episode with someone considering plastic surgery—the right knowledge can save a life.

A 25-year-old pregnant woman presents with a 1-day history of progressive pain and swelling. The foot is cold, pulseless and neurologic function is deteriorating by the hour. Imaging shows a massive iliofemoral DVT. Now both the limb and the pregnancy are threatened. Do you anticoagulate, thrombolyse or operate? Join us as we break down the management and decision making behind this rare but devastating case.Hosts:·      Christian Hadeed -PGY 4 General Surgery, Brookdale Hospital Medical Center·      Paul Haser -Division Chief, Vascular Surgery, Brookdale Hospital Medical Center·      Andrew Harrington, Vascular surgery, Brookdale Hospital Medical Center·      Lucio Flores, Vascular surgery, Brookdale Hospital Medical CenterLearning objectives:-       Recognize the clinical presentation and pathophysiology of phlegmasia cerulea dolens-       Describe how pregnancy affects decision making in patients with phlegmasia and venous thromboembolic disease-       Discuss the goals of treatment for patients with DVT's and identify when operative intervention is indicated-       Describe the sequelae of DVT's and how this relates to post thrombotic syndrome-       Review the indications, risks, and limitations of anticoagulation, catheter-directed thrombolysis, thrombectomy, and fasciotomy in the management of DVT and phlegmasia.-       Explain the role of IVUS in managing venous thromboembolic disease and May Thurner syndromeReferences:-       Vedantham, S., Goldhaber, S. Z., Julian, J. A., Kahn, S. R., Jaff, M. R., Cohen, D. J., Magnuson, E., Razavi, M. K., Comerota, A. J., Gornik, H. L., Murphy, T. P., Lewis, L., Duncan, J. R., Nieters, P., Derfler, M. C., Filion, M., Gu, C.-S., Kee, S., Schneider, J., … Kearon, C. (2017). Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. New England Journal of Medicine, 377(23), 2240–2252. https://doi.org/10.1056/NEJMoa1615066-       Gomes, M. S., Guimarães, M., & Montenegro, N. (2019). Thrombolysis in pregnancy: A literature review. Journal of Maternal-Fetal & Neonatal Medicine, 32(14), 2418–2428. https://doi.org/10.1080/14767058.2018.1438402-       Mangla, A., & Hamad, H. (2023). May-Thurner syndrome. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554377/-       Bates, S. M., Rajasekhar, A., Middeldorp, S., McLintock, C., Rodger, M. A., James, A. H., et al. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: Venous thromboembolism in the context of pregnancy. Blood Advances, 2(22), 3317–3359. https://doi.org/10.1182/bloodadvances.2018024802-       Kahn, S. R., Comerota, A. J., Cushman, M., Evans, N. S., Ginsberg, J. S., Goldenberg, N. A., et al. (2014). The postthrombotic syndrome: Evidence-based prevention, diagnosis, and treatment strategies. Circulation, 130(18), 1636–1661. https://doi.org/10.1161/CIR.0000000000000130 https://pubmed.ncbi.nlm.nih.gov/25246013/Sponsor URL: https://www.goremedical.com/If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Could mushrooms hold the secret to better gut health, lower cholesterol, and can they protect your brain? Today, Professor Robin May, a leading microbiologist and the UK Government's Chief Scientific Officer, explores why our interest in mushrooms has exploded. He explains why they are not just another vegetable but could hold the key to better gut health, brain health, immune health, and lower cholesterol. By the end of the episode, you'll know which health claims about mushrooms are real, which are exaggerated and where the science is just too early to trust. You'll have a solid understanding of what mushrooms are really doing inside our bodies and how to unlock the secret health powers they hold. Should mushrooms become a regular part of your weekly shop rather than an occasional side dish? And if fungi have evolved alongside humans for millions of years, what else might they reveal about the future of nutrition and health?

Welcome to the emDOCs.net podcast! Join us as we review our high-yield posts from our website emDOCs.net.Today on the emDOCs cast with Brit Long (@long_brit), we cover how to evaluate and manage acute limb ischemia. To continue to make this a worthwhile podcast for you to listen to, we appreciate any feedback and comments you may have for us. Please let us know!Subscribe to the podcast on one of the many platforms below:Apple iTunesSpotifyGoogle Play Send us Fan Mail

Send us Fan MailWe're joined by Jim's wife for this one.  We cover a bit of ground and have some laughs.Big WhackMoney back guaranteeIncenseRIP Wolves and WildVictoire'MN sports futilityDystopianFacial recognitionSchlitzYungblud concert reviewThe opposite of David Lee RothMark's Green Day connectionSongs of the Week:Vascular--PierreLove Removal Machine--The CultHappy Birthday Mark!#NewtsAppleValleyMNTheAscertainers@gmail.comPierre - "Vascular"The Cult - Love Removal Machine HD - YouTubeYUNGBLUD - Hello Heaven, Hello (Official Music Video) - YouTube (the good part starts at 2:50)Dillinger Four - Doublewhiskeycokenoice  (You be the judge--did Green Day rip them off?)

Medicine isn't what it used to be—not for the people practicing it. Independent physicians are becoming the exception, not the norm, as more doctors move into hospital systems, corporate groups, and academic networks. At the same time, the pipeline of specialists isn't keeping pace with growing patient needs, particularly in complex fields like vascular surgery, where workforce models show demand is set to outstrip supply in the years ahead. The result is a profession being pulled in two directions at once: toward consolidation on one hand, and rising clinical demand on the other.In that kind of environment, what does it really mean to make a major career move—and how do you weigh opportunity, stability, and personal priorities when the ground beneath the profession is shifting?That question sits at the heart of the latest episode of I Don't Care. Host Dr. Kevin Stevenson sits down with vascular surgeon Dr. Bradley Trinidad to unpack the realities behind a major geographic and professional transition. Their conversation explores how evolving medical technology, shifting employment models, and personal values intersect to shape modern physician careers.Key takeaways from the episode…Family can outweigh career momentum: Dr. Trinidad left a high-volume, successful practice to prioritize proximity to family and improve quality of life.Alignment is everything in hospital employment: Success depends on shared goals between physician and institution, especially in a system where most doctors are now employed.The future of vascular surgery is less invasive—and more complex: Advances in endovascular techniques are reducing the need for open surgery while increasing the need for specialized expertise.Dr. Bradley Trinidad is a board-certified vascular surgeon with expertise in both complex open and advanced endovascular procedures. He serves as Director of Vascular and Endovascular Surgery at Ascension Providence in Waco, Texas, where he leads program development and the delivery of high-acuity vascular care. He previously founded and led the vascular division at Northwest Texas Hospital and now contributes to surgical education as a Clinical Assistant Professor at Texas Tech University Health Sciences Center.

It's PodQuiz Monday! Test your knowledge from a recent episode with a quick set of audio flashcards designed to reinforce what you learned. These mini-reviews are a great way to study on the go, and they give you a taste of what it's like inside Study Sesh, my audio study tool for busy nursing students. If you need a brush-up on vascular assessments before you do this podquiz, I've got you covered in episode ENCORE! #274: Introduction to Vascular Assessment.

Every other week I republish one of my most popular or impactful episodes from my backlog of over 450 episodes. This week I'm highlighting Episode 274, which walks you through how to perform a vascular assessment. ___________________ ⁠Full Transcript⁠- Read the article "Performing a Vascular Assessment" and view references ⁠Nursing School Survival Blueprint⁠ - Nursing school gets easier when you have a system. This free Blueprint walks you through the key shifts that separate struggling students from thriving ones — download it and start applying them this week.

Dr. Clint Sliker breaks down the critical imaging findings of cardiac and non-thoracic vascular trauma, highlighting how these rare but life-threatening injuries appear on CT. He shares practical insights to help radiologists recognize subtle signs, choose the right protocols, and maintain a high index of suspicion in high-stakes trauma cases. Imaging of Cardiac and NonaorticThoracic Vascular Trauma. Costenbader and Beheshtian et al. RadioGraphics 2026; 46(2):e250097. 

Vascular trauma care looks a lot different when the OR is improvised, supplies are limited, and limb salvage decisions cannot wait. On this episode of the BackTable Podcast, host Dr. Sabeen Dhand interviews vascular surgeon Dr. Ahmad Hussain, a Southern California private-practice “hired gun” who volunteered on a WHO/UN-coordinated humanitarian mission to Gaza after an orthopedic colleague requested vascular surgeons due to widespread limb loss. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction04:02 - Why Volunteer In Gaza?07:41 - Logistics and Crossing Into Gaza10:45 - Hospital as Refugee Camp13:34 - First Vascular Trauma Case18:24 - Mass Casualty Triage23:20 - Kids Guiding Doctors27:09 - Evacuation Uncertainty32:03 - Would You Go Back?37:55 - How to Volunteer39:30 - Show Wrap Up and Credits --- More about this episode Dr. Hussain describes entering through the Rafah border with suitcases of medical supplies, working in a hospital functioning as a refugee camp for tens of thousands, and treating shrapnel-related vascular trauma with limited imaging (mainly ultrasound and X-ray), scarce anesthesia, and minimal surgical resources, relying heavily on skilled local medical students and residents. He recounts mass-casualty triage, the emotional impact of caring for injured children, bonding with the children who assisted the volunteers, and the dangerous, militarized evacuation via Israel with U.S. embassy assistance. He says he wants to return, but notes tightened restrictions and dwindling aid, and he recommends other organizations, noting any specialty of medical professionals should consider volunteering. --- Resources Gift of Disability Alleviation (GODA)https://indushospital.ca/appeal/gift-of-disability-alleviation-goda/ --- BackTable Vascular & Interventional (VI) is the go-to podcast for interventional radiologists, vascular surgeons, and interventional cardiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

CardioNerds (Drs. Natalie Marrero, Shivani Reddy, and Rebecca S. Steinberg), discuss the role of SGLT2i in cancer therapy-related cardiac dysfunction (CTRCD) with Dr. Manu Murali Mysore. This episode was produced as part of the CardioNerds Academy curriculum by House Taussig under the guidance of House Chief, Dr. Natalie Marrero, and Academy Program Director, Dr. Gurleen Kaur. A matching review article will be published in US Cardiology Review, the official journal of CardioNerds. Audio editing for this episode was performed by CardioNerds Intern, Dr. Julia Marques Fernandes. Summary: Cancer therapy-related cardiac dysfunction (CTRCD) spans a spectrum from subclinical biomarker elevation to overt heart failure, with risk amplified by preexisting cardiovascular disease, diabetes, hypertension, obesity, and exposure to therapies, such as anthracyclines, HER2-targeted therapies, or radiation. This episode explores the emerging and promising role of SGLT2 inhibitors as a cardioprotective adjunct in cardio-oncology — examining mechanisms, clinical evidence, ongoing trials, and critical knowledge gaps — while affirming that guideline-directed medical therapy remains the cornerstone of prevention and treatment. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Cardio-Oncology PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls CTRCD is a spectrum — catch it early. CTRCD ranges from subclinical injury detected by imaging and biomarkers to overt heart failure. Early identification in high-risk patients (preexisting CVD, diabetes, HTN, obesity, anthracycline/HER2/radiation exposure) is essential, and early initiation of guideline-directed medical therapy — including ACE inhibitors/ARBs/ARNIs, mineralocorticoid receptor antagonists, and beta-blockers — remains the backbone of prevention and treatment to preserve LVEF and allow safe continuation of cancer therapy. SGLT2 inhibitors are a promising new pillar of cardioprotection in cardio-oncology. They act through a unique combination of mechanisms: renal effects, metabolic reprogramming of the myocardium, anti-inflammatory and antioxidant pathways, and vascular fibrosis modulation — making them a compelling complement to standard therapies rather than a replacement. Early clinical data is encouraging but not yet definitive. The 2024 EMPACARD-PILOT trial demonstrated preserved LVEF and reduced CTRCD in higher-risk patients with diabetes or kidney disease. Ongoing trials — EMPACT and PROTECT — are actively exploring SGLT2 inhibitors for primary prevention during anthracycline and HER2-targeted therapy. SGLT2 inhibitors are NOT yet indicated for ICI-related myocarditis. Immune checkpoint inhibitor (ICI)-related myocarditis is mechanistically immune-driven. While SGLT2 inhibitors have theoretically anti-inflammatory benefits, there is currently no clinical evidence to support their use in this specific setting. The use of SGLT2 inhibitors should be guided by patient risk, existing indications, and ongoing research. Large prospective trials, clarity on timing and patient selection, long-term safety data, and deeper mechanistic understanding in humans remain the most urgent gaps in the field before broader adoption can be recommended. References Theofilis P, Vlachakis PK, Oikonomou E, et al. Cancer therapy-related cardiac dysfunction: A review of current trends in epidemiology, diagnosis, and treatment. Biomedicines. 2024;12(12):2914. doi:10.3390/biomedicines12122914. https://pubmed.ncbi.nlm.nih.gov/39767820/ Lyon AR, Dent S, Stanway S, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Eur J Heart Fail. 2020;22(11):1945-1960. doi:10.1002/ejhf.1920. https://pmc.ncbi.nlm.nih.gov/articles/PMC8019326/ Li X, Li Y, Zhang T, et al. Role of cardioprotective agents on chemotherapy-induced heart failure: A systematic review and network meta-analysis of randomized controlled trials. Pharmacol Res. 2020;151(104577):104577. doi:10.1016/j.phrs.2019.104577. https://pubmed.ncbi.nlm.nih.gov/31790821/ Lee YH, Lim S, Davies MJ. Cardiometabolic and renal benefits of sodium-glucose cotransporter 2 inhibitors. Nat Rev Endocrinol. 2025;21(12):783-798. doi:10.1038/s41574-025-01170-4. https://pubmed.ncbi.nlm.nih.gov/40935880/ Dabour MS, George MY, Daniel MR, Blaes AH, Zordoky BN. The cardioprotective and anticancer effects of SGLT2 inhibitors: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 2024;6(2):159-182. doi:10.1016/j.jaccao.2024.01.007. https://pubmed.ncbi.nlm.nih.gov/38774006/ Armillotta M, Angeli F, Paolisso P, et al. Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure. Pharmacol Ther. 2025;270(108861):108861. doi:10.1016/j.pharmthera.2025.10886. https://pubmed.ncbi.nlm.nih.gov/40245989/ Góes-Santos BR, Castro PC, Girardi ACC, Antunes-Correa LM, Davel AP. Vascular effects of SGLT2 inhibitors: evidence and mechanisms. Am J Physiol Cell Physiol. 2025;329(4):C1150-C1160. doi:10.1152/ajpcell.00569.2025. https://pubmed.ncbi.nlm.nih.gov/40908107/ Daniele AJ, Gregorietti V, Costa D, López-Fernández T. Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD – PILOT trial. CardioOncology. 2024;10(1):58. doi:10.1186/s40959-024-00260-y. https://pubmed.ncbi.nlm.nih.gov/39237985/ Clinicaltrials.gov. Clinicaltrials.gov. Accessed April 16, 2026. https://clinicaltrials.gov/study/NCT05271162 Greco A, Quagliariello V, Rizzo G, et al. SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial. CardioOncology. 2025;11(1):79. doi:10.1186/s40959-025-00368-9. https://pmc.ncbi.nlm.nih.gov/articles/PMC12400668/ Key Guideline Reference: Lyon AR, López-Fernández T, Couch LS, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS). Eur Heart J Cardiovasc Imaging. 2022;23(10):e333-e465. doi:10.1093/ehjci/jeac106. https://pubmed.ncbi.nlm.nih.gov/36017575/ Be sure to check out the corresponding review article on the cardioprotective role of SGLT2 inhibitors in CTRCD that will be published in US Cardiology Review, the official journal of CardioNerds. Additionally, please reference CardioNerds Cardio-Oncology Episodes 261 and 274 for related content.

As interventional radiology cements its position as a primary clinical responder for acute arterial hemorrhage, what if you could achieve rapid and durable arterial occlusion with a single, highly deliverable device? In this episode of the BackTable Podcast, Dr. Alex Villalobos (UNC), Dr. Nima Kokabi (UNC), and Dr. Brian Funaki (UChicago) join host Dr. Kavi Krishnasamy to explore the shifting paradigms of arterial embolization in a case-based discussion highlighting modern vascular plug technologies.--- Get the BackTable app https://www.backtable.com/app --- This podcast is supported by Okami Medicalhttps://okamimedical.com/ --- Timestamps 00:00 - Introduction01:24 - Trauma Activation Workflow06:42 - Empiric Arterial Embolization Indications10:40 - Embolic Agent Preferences and Value Analysis17:18 - Embolics on the Shelf19:32 - LOBO Plug Use Cases20:58 - Case 1: Abdominal Wall Hematoma23:54 - LOBO Advantages, Cost, and Microcatheter Compatibility26:33 - Alternative Access Approaches30:31 - LOBO Sizing and Trackability35:26 - Pusher Wire Features38:20 - Delivery Catheter Requirements43:41 - Case 2: Retroperitoneal Bleed45:15 - LOBO Deployment Technique49:41 - Case 3: Splenic Trauma53:51 - Occlusion Time and Adjunct Embolics57:07 - Closing Remarks --- More about this episode The panel begins by discussing the range of embolic options and combinations at their disposal, sharing their preferences and treatment algorithms in various clinical scenarios. In particular, they emphasize the need for tools that provide immediate, predictable occlusion without the technical burden and cost of needing to deploy multiple embolic agents. The physicians go on to focus on Okami Medical's LOBO vascular plug as a primary solution for rapid vessel occlusion, highlighting the micro-pore architecture and unique deliverability through microcatheters that make it advantageous for precise positioning and reliable embolization. Exploring its use in cases including rectus sheath hematomas, retroperitoneal bleeding, and splenic trauma, the physicians detail the technical nuances of sizing and positioning the LOBO as well as the long-term advantages of its artifact-free design. This episode ultimately underscores a growing preference for streamlined arterial embolization workflows that prioritize rapid stasis and clinical predictability while leveraging the strengths of a multimodal embolic toolkit.

Shot Targets Clogged Arteries Blocked arteries are not the main cause of heart attacks. Unstable plaque driven by oxidation, inflammation, and high insulin is. In this episode, Ben explains the 5 key drivers of arterial damage: Oxidized LDL Endothelial inflammation Low nitric oxide High triglycerides Chronically elevated insulin He shares a simple 60-second vascular support shot designed to: Support nitric oxide Lower insulin spikes Reduce inflammation Protect LDL from oxidation Key ingredients include beetroot or lemon, apple cider vinegar, ginger or turmeric, and high polyphenol fresh pressed olive oil. Small daily habits shape long-term heart health. Precision over panic.